Very low levels of cholecystokinin octapeptide activate Na-pump in the cerebral cortex of CCK2 receptor-deficient mice

Int J Dev Neurosci. 2006 Oct;24(6):395-400. doi: 10.1016/j.ijdevneu.2006.05.005. Epub 2006 Jul 5.

Abstract

This study provides the first evidence that CCK-8 (0.01 pM to 0.1 mM) stimulates Na,K-ATPase in the cortical membranes of wild-type and CCK(2) receptor-deficient mice. In each genotype, the maximal stimulation was about 40%. Homozygous mice revealed substantially lower EC50 (4 pM) than heterozygous (37 pM) or wild-type animals (682 pM). In homozygous CCK2 receptor-deficient mice, the expression of CCK1 receptor gene was 5-fold higher than in wild-type animals. CCK1 receptor antagonist devazepide counteracted effect of CCK-8 in all three genotypes, whereas CCK2 receptor antagonist L-365, 260 showed significant antagonism in wild-type and heterozygous mice. The cooperativity of Na,K-ATPase for Na+, but not for K+, was lost in homozygous mice. Altogether, very low concentrations of CCK-8 via CCK1 and CCK2 receptors stimulate Na,K-ATPase in the cerebral cortex. CCK2 receptor-deficiency leads to the altered functionality of Na,K-ATPase that might be compensated by CCK1 receptor mediated influence of CCK (and its agonists) on the enzyme.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzodiazepinones / metabolism
  • Cerebral Cortex / metabolism*
  • Devazepide / metabolism
  • Female
  • Hormone Antagonists / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Phenylurea Compounds / metabolism
  • Receptor, Cholecystokinin B / antagonists & inhibitors
  • Receptor, Cholecystokinin B / genetics
  • Receptor, Cholecystokinin B / metabolism*
  • Sincalide / metabolism*
  • Sodium-Potassium-Exchanging ATPase / metabolism*

Substances

  • Benzodiazepinones
  • Hormone Antagonists
  • Phenylurea Compounds
  • Receptor, Cholecystokinin B
  • L 365260
  • Sodium-Potassium-Exchanging ATPase
  • Devazepide
  • Sincalide